CALLABLE KICK-IN GOAL LINKED TO WORST OF - SWISSCOM N/ROCHE GS/UBS/ABB LTD Share Price

Certificat

KNERDU

CH1229772657

Delayed Swiss Exchange 08:50:00 05/09/2023 pm IST
98.8 CHF +0.05% Intraday chart for CALLABLE KICK-IN GOAL LINKED TO WORST OF - SWISSCOM N/ROCHE GS/UBS/ABB LTD
1 month+1.02%
3 months+2.65%

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
KNERDU
ISINCH1229772657
Date issued 07/12/2022
Strike 301.2 CHF
Maturity 07/06/2024 (26 Days)
Parity 0.3 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 102.7 CHF
Lowest since issue 94.2 CHF
Spread 10 CHF
Spread %1.00%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus
  1. Stock Market
  2. Certificates
  3. KNERDU Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW